Agilent Technologies, Inc.

NYSE:A Stock Report

Market Cap: US$38.0b

Agilent Technologies Past Earnings Performance

Past criteria checks 5/6

Agilent Technologies has been growing earnings at an average annual rate of 11.3%, while the Life Sciences industry saw earnings growing at 11.7% annually. Revenues have been growing at an average rate of 5.9% per year. Agilent Technologies's return on equity is 21.9%, and it has net margins of 19.8%.

Key information

11.3%

Earnings growth rate

12.7%

EPS growth rate

Life Sciences Industry Growth21.5%
Revenue growth rate5.9%
Return on equity21.9%
Net Margin19.8%
Last Earnings Update31 Oct 2024

Recent past performance updates

Agilent Technologies' (NYSE:A) Profits May Not Reveal Underlying Issues

Sep 09
Agilent Technologies' (NYSE:A) Profits May Not Reveal Underlying Issues

Recent updates

Is There Now An Opportunity In Agilent Technologies, Inc. (NYSE:A)?

Dec 13
Is There Now An Opportunity In Agilent Technologies, Inc. (NYSE:A)?

Analyst Estimates: Here's What Brokers Think Of Agilent Technologies, Inc. (NYSE:A) After Its Full-Year Report

Nov 28
Analyst Estimates: Here's What Brokers Think Of Agilent Technologies, Inc. (NYSE:A) After Its Full-Year Report

Agilent Q4: Expecting Market Recovery In 2025

Nov 26

Agilent Technologies' (NYSE:A) Shareholders Will Receive A Bigger Dividend Than Last Year

Nov 26
Agilent Technologies' (NYSE:A) Shareholders Will Receive A Bigger Dividend Than Last Year

Here's Why Agilent Technologies (NYSE:A) Can Manage Its Debt Responsibly

Oct 21
Here's Why Agilent Technologies (NYSE:A) Can Manage Its Debt Responsibly

With EPS Growth And More, Agilent Technologies (NYSE:A) Makes An Interesting Case

Sep 23
With EPS Growth And More, Agilent Technologies (NYSE:A) Makes An Interesting Case

Agilent Technologies' (NYSE:A) Profits May Not Reveal Underlying Issues

Sep 09
Agilent Technologies' (NYSE:A) Profits May Not Reveal Underlying Issues

Agilent: A 'Buy' Due To Growing Biopharma, PFAS, And Semi

Aug 23

A Look At The Intrinsic Value Of Agilent Technologies, Inc. (NYSE:A)

Aug 14
A Look At The Intrinsic Value Of Agilent Technologies, Inc. (NYSE:A)

Agilent: Making A Move To Ignite Some Growth

Jul 25

Agilent Technologies (NYSE:A) Has A Pretty Healthy Balance Sheet

Jul 15
Agilent Technologies (NYSE:A) Has A Pretty Healthy Balance Sheet

Is Agilent A Buy Before Earnings? Examining The Pros And Cons

May 23

Should You Investigate Agilent Technologies, Inc. (NYSE:A) At US$154?

May 22
Should You Investigate Agilent Technologies, Inc. (NYSE:A) At US$154?

Subdued Growth No Barrier To Agilent Technologies, Inc.'s (NYSE:A) Price

May 07
Subdued Growth No Barrier To Agilent Technologies, Inc.'s (NYSE:A) Price

These 4 Measures Indicate That Agilent Technologies (NYSE:A) Is Using Debt Reasonably Well

Apr 05
These 4 Measures Indicate That Agilent Technologies (NYSE:A) Is Using Debt Reasonably Well

Agilent Technologies: Cash Flow Returns On Investments And Conventional All Point To A Hold

Mar 12

Agilent Technologies Hit A Homerun

Dec 24

Agilent: A Wide Moat Company Expected To Return To Growth In 2024 (Rating Upgrade)

Dec 08

Agilent Technologies: Looking Undervalued Heading Into Earnings

Nov 17

Agilent: Dips Into GARP Territory, Shares At A Crucial Spot On The Chart

Sep 26

Agilent Technologies - A Wealth Compounder 30% Below Its Highs

Jul 13

Revenue & Expenses Breakdown

How Agilent Technologies makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

NYSE:A Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Oct 246,5101,2891,568479
31 Jul 246,4971,4131,764456
30 Apr 246,5911,2421,518465
31 Jan 246,7351,2361,553478
31 Oct 236,8331,2401,578481
31 Jul 236,9941,1331,281486
30 Apr 237,0401,3511,579484
31 Jan 236,9301,3231,585473
31 Oct 226,8481,2541,578467
31 Jul 226,6591,3281,552464
30 Apr 226,5271,2631,548461
31 Jan 226,4451,2051,571455
31 Oct 216,3191,2101,562441
31 Jul 216,1429901,562426
30 Apr 215,8179251,464405
31 Jan 215,5308101,404396
31 Oct 205,3397191,395397
31 Jul 205,2236911,377398
30 Apr 205,2366831,446407
31 Jan 205,2367641,405406
31 Oct 195,1631,0711,358404
31 Jul 195,0901,0721,343406
30 Apr 195,0191,1171,290402
31 Jan 194,9871,1401,301395
31 Oct 184,9143161,322387
31 Jul 184,8092981,284372
30 Apr 184,7202371,269362
31 Jan 184,6161961,235354
31 Oct 174,4726841,205341
31 Jul 174,3946331,173330
30 Apr 174,3245821,167329
31 Jan 174,2415091,159326
31 Oct 164,2024621,174325
31 Jul 164,1264761,184324
30 Apr 164,0964651,175317
31 Jan 164,0404661,170317
31 Oct 154,0384381,189327
31 Jul 154,0463061,189340
30 Apr 154,0412561,184347
31 Jan 154,0662041,196353
31 Oct 144,0482321,199358
31 Jul 144,7234351,325434
30 Apr 145,3665401,490518
31 Jan 146,1106661,654604

Quality Earnings: A has high quality earnings.

Growing Profit Margin: A's current net profit margins (19.8%) are higher than last year (18.1%).

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: A's earnings have grown by 11.3% per year over the past 5 years.

Accelerating Growth: A's earnings growth over the past year (4%) is below its 5-year average (11.3% per year).

Earnings vs Industry: A earnings growth over the past year (4%) exceeded the Life Sciences industry -4.7%.

Return on Equity

High ROE: A's Return on Equity (21.9%) is considered high.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/20 23:10
End of Day Share Price 2024/12/20 00:00
Earnings2024/10/31
Annual Earnings2024/10/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Agilent Technologies, Inc. is covered by 43 analysts. 18 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
James Francis MainwaringAtlantic Equities LLP
Catherine Ramsey SchulteBaird
Ishan MajumdarBaptista Research